US Physical Therapy (USPH) Misses Q3 EPS by 1c, Slight Beat on Revenues; Offers FY17 EPS Guidance Below Consensus
Get Alerts USPH Hot Sheet
Revenue Growth %: +7.1%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q3 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $103 million versus the consensus estimate of $102.48 million.
Management Updates 2017 Earnings Guidance
Management previously disclosed that because of hurricanes Harvey and Irma the Company lost approximately 8,500 patient visits, which was estimated to have a financial impact to earnings of $.03 per share. Primarily as the result of the impact from those storms we currently expect the Company’s operating results for the year 2017 to be in the range of $25.4 million to $26.5 million and $2.02 to $2.10 in diluted earnings per share as compared to $24.3 million and $1.94, respectively, in the year 2016. This earnings range is based on an assumed annual corporate tax rate of approximately 37%. Please note that management’s guidance range represents projected earnings from existing operations excluding potential future acquisitions. The annual guidance figures will not be updated unless there is a material development that causes management to believe that earnings will be significantly outside the given range.
GUIDANCE:
US Physical Therapy sees FY2017 EPS of $2.02-$2.10, versus the consensus of $2.12.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- C.H. Robinson acquires DeSpir Logistics for $75 million
- AXT appoints Tracy Liu to its board of directors
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share